PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 78 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $283,000 | +3.7% | 38,428 | -4.5% | 0.00% | 0.0% |
| Q2 2017 | $273,000 | -30.9% | 40,235 | -3.8% | 0.00% | -50.0% |
| Q1 2017 | $395,000 | +7.6% | 41,813 | -1.6% | 0.00% | 0.0% |
| Q4 2016 | $367,000 | +31.1% | 42,505 | -3.8% | 0.00% | +100.0% |
| Q3 2016 | $280,000 | +49.7% | 44,204 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $187,000 | -3.1% | 44,204 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $193,000 | -32.0% | 44,204 | -4.7% | 0.00% | 0.0% |
| Q4 2015 | $284,000 | +9.7% | 46,383 | +2.3% | 0.00% | 0.0% |
| Q3 2015 | $259,000 | -23.4% | 45,320 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $338,000 | +11.2% | 45,320 | -10.9% | 0.00% | 0.0% |
| Q1 2015 | $304,000 | -24.9% | 50,889 | -4.9% | 0.00% | -50.0% |
| Q4 2014 | $405,000 | +43.6% | 53,539 | -1.4% | 0.00% | +100.0% |
| Q3 2014 | $282,000 | +20.5% | 54,314 | +0.2% | 0.00% | 0.0% |
| Q2 2014 | $234,000 | +8.8% | 54,184 | +3.3% | 0.00% | 0.0% |
| Q1 2014 | $215,000 | -13.0% | 52,462 | +13.4% | 0.00% | 0.0% |
| Q4 2013 | $247,000 | -32.1% | 46,261 | -36.0% | 0.00% | -50.0% |
| Q3 2013 | $364,000 | +33.3% | 72,294 | +18.1% | 0.00% | +100.0% |
| Q2 2013 | $273,000 | – | 61,218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 8,951,169 | $54,871,000 | 3.38% |
| Virtus ETF Advisers LLC | 103,807 | $636,000 | 1.75% |
| BKS ADVISORS, LLC | 291,150 | $1,785,000 | 0.92% |
| Piermont Capital Management Inc. | 363,549 | $2,229,000 | 0.71% |
| TUDOR INVESTMENT CORP ET AL | 2,370,760 | $14,532,000 | 0.41% |
| SEARLE & CO. | 60,000 | $349,000 | 0.34% |
| TURNER INVESTMENTS LLC | 252,785 | $1,550,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 891,672 | $5,466,000 | 0.31% |
| Phocas Financial Corp. | 635,333 | $3,895,000 | 0.30% |
| TFS CAPITAL LLC | 398,283 | $2,441,000 | 0.26% |